Susanne S. Rauh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Susanne S. Rauh has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Alexandra Ljimani
Department of Diagnostic and Interventional Radiology, Medical Faculty and University Hospital Düsseldorf Heinrich‐Heine‐University Düsseldorf Düsseldorf Germany
1 shared publication- Amita Shukla-Dave
Department of Medical Physics Memorial Sloan Kettering Cancer Center New York New York USA
1 shared publication - Andreas Wetscherek
Joint Department of Physics The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust London UK
1 shared publication Christian Federau
Department of Neuroradiology University of Zürich Zürich Switzerland
1 shared publication- Dan Wu
Key Laboratory for Biomedical Engineering of Ministry of Education, Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou 310027, China
1 shared publication - David A. Reiter
Department of Radiology and Imaging Sciences Emory University Atlanta Georgia USA
1 shared publication
Latest Publications
- 17 September 2026
- Published by Springer Nature
- p. 1-20
Inflammatory Myopathies
- Top Cited PapersOpen Access
- 19 March 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 63 (6) , 1782-1801
Towards Clinical Translation of Intravoxel Incoherent Motion MRI : Acquisition and Analysis Consensus Recommendations
Intravoxel incoherent motion (IVIM) MRI allows for simultaneous assessment of tissue microcirculation (perfusion) and diffusion of water. In single‐center studies, IVIM has shown great potential for diagnosis, treatment outcome prediction, and treatment monitoring for many different diseases and organs. However, heterogeneity in data acquisition protocols, pre‐processing pipelines, and post‐processing routines yields differences in reported IVIM parameters, which has constrained large‐scale deployment of IVIM. Moreover, deploying IVIM protocols and analysis typically requires technical expertise, further challenging wider use, especially for clinicians. In this consensus paper, to accelerate the deployment of IVIM, we provide recommendations and harmonize protocols for brain, breast, kidney, liver, muscle, and pancreas IVIM studies. For this goal we organized multiple questionnaires and held a dedicated workshop. To ensure a level of standardized, reproducible results, without restricting innovation, we suggest a small subset of b ‐values to always be measured and analyzed separately, and to which more extensive b ‐value sampling can be added for advanced investigations. We further introduce detailed recommendations on acquisition protocols and analysis pipelines. To increase consistency, repeatability, and reproducibility, we highly recommend that these protocols and pipelines be deployed by scientists and clinicians for IVIM studies. For advanced users who desire different protocols or analysis approaches, we suggest adding results from our suggested protocols and analysis pipeline in the supplemental part of their paper to enable retrospective studies.
- 19 March 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 63 (6) , 1782-1801
Top Cited PapersOpen AccessTowards Clinical Translation of Intravoxel Incoherent Motion MRI : Acquisition and Analysis Consensus Recommendations
Intravoxel incoherent motion (IVIM) MRI allows for simultaneous assessment of tissue microcirculation (perfusion) and diffusion of water. In single‐center studies, IVIM has shown great potential for diagnosis, treatment outcome prediction, and treatment monitoring for many different diseases and organs. However, heterogeneity in data acquisition protocols, pre‐processing pipelines, and post‐processing routines yields differences in reported IVIM parameters, which has constrained large‐scale deployment of IVIM. Moreover, deploying IVIM protocols and analysis typically requires technical expertise, further challenging wider use, especially for clinicians. In this consensus paper, to accelerate the deployment of IVIM, we provide recommendations and harmonize protocols for brain, breast, kidney, liver, muscle, and pancreas IVIM studies. For this goal we organized multiple questionnaires and held a dedicated workshop. To ensure a level of standardized, reproducible results, without restricting innovation, we suggest a small subset of b ‐values to always be measured and analyzed separately, and to which more extensive b ‐value sampling can be added for advanced investigations. We further introduce detailed recommendations on acquisition protocols and analysis pipelines. To increase consistency, repeatability, and reproducibility, we highly recommend that these protocols and pipelines be deployed by scientists and clinicians for IVIM studies. For advanced users who desire different protocols or analysis approaches, we suggest adding results from our suggested protocols and analysis pipeline in the supplemental part of their paper to enable retrospective studies.